Pretty amazing stuff, considering that the compound was first tested with the hope of prolonging the lives of CML patients by only months, and is now approved for the treatment of 10(!) cancers. Pretty remarkable story of the drug’s development…
|
||||||
|
|
A Conversation With Brian J. Druker, M.D. – Researcher Behind the Drug Gleevec – Interview – NYTimes.com |
|||||
|
Copyright © 2010 Renaissance Pundit - All Rights Reserved |
||||||
